Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Int J Med Inform ; 111: 17-23, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29425629

RESUMEN

INTRODUCTION: The advancements in telemedicine provide the possibility to send photos of hematuria cases to professionals for further evaluation. We aimed to evaluate the inter-rater reliability of WhatsApp use in the evaluation of hematuria. MATERIALS AND METHODS: Between December 2014 and April 2016, 212 patients were evaluated prospectively for hematuria by 2 groups of urologists; Group A: in direct contact with patients for evaluation; Group B: "blind" urologist who had no access to the patients' data but received pictures via WhatsApp. Two photos of voided urine in a sterile container were taken and sent using WhatsApp. The opinions of Group A and B about the grade of hematuria were evaluated. Shapiro-Wilk test and Fleiss' kappa statistics were used for statistical analyses. RESULTS: The median age of patients was 71 (min 22, max 96). The Group A urologists were in accordance in 96.22% of cases. Group B urologists had common opinions in 99.5% (n = 203) and there was almost perfect agreement between 2 groups (λ = 0.992). The number of common opinions among "blind" urologists is more than the number of common opinions among the consultants. When further classification is performed as serious and non-serious hematuria, the rate of misdiagnosing serious cases is approximately 6.5-7%. However, using WhatsApp, the urologists can differentiate normal urine and any form of hematuria with 100% accuracy. CONCLUSION: It is possible to evaluate hematuria remotely and also reduce unnecessary costs of services for hematuria of mild clinical significance by using telemedicine. WhatsApp can provide valuable aid to tertiary hospitals where the urologist is not always present as well as in rural areas.


Asunto(s)
Hematuria/terapia , Aplicaciones Móviles/estadística & datos numéricos , Telemedicina , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Hematuria/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Adulto Joven
2.
Arch Ital Urol Androl ; 89(2): 97-101, 2017 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-28679177

RESUMEN

OBJECTIVES: Analyze the oncologic and functional outcomes in patients affected by low risk prostate cancer underwent prostate cryotherapy. Materiasl and methods: It's a prospective tricentric study of 434 patients treated with prostate cryoablation for low risk prostate cancer. By low risk we refer to the D'Amico's risk classification. Two cycles of freezing/thawing are run for each patient following the technique described by Onik. RESULTS: For the 434 patients, the median age was 66 years with a standard deviation of ± 6.68, the average PSA was 6.17 ng/d/L, the median 5.55 with a standard deviation of ± 2.13, the mean prostate volume was 35.59 cc, the median 34.00 cc, with a standard deviation of ± 7.89. Biochemical failure occurred in 67 patients (15.4%). Pre-operative erectile function in men was distributed as follows: severe in 95 patients (19.2%), moderate in 95 (19.2%), medium-moderate in 180 (36.4%), mild in 92 (18.6%), with no dysfunction in 32 (6.5%) patients. Post-operative erectile function, measured 1 month after cryotherapy, was distributed as follows: severe in 321 (65%) patients, moderate in 69 (14%), medium-moderate in 79 (16%), mild in 23 (4.7%), and no dysfunction in only 2 patients (0.4%). Post-operative erectile function after 3 months was distributed as follows: severe in 233 (47.2%) patients, moderate in 66 (13.4%), medium-moderate in 122 (24.7%), mild in 65 (13.2%), and no dysfunction in 8 patients (1.6%). Urinary incontinence was present in 21 patients (4.8%) after 3 months while it dropped to 13 patients (2.9%) after 6 months. CONCLUSIONS: Cryotherapy in the treatment of prostate cancer remains a viable alternative. The availability of new cryoprobes and the use of new diagnostic means such as fusion magnetic resonance will make this more precise and more effective method.


Asunto(s)
Crioterapia , Neoplasias de la Próstata/terapia , Anciano , Disfunción Eréctil/etiología , Humanos , Masculino , Erección Peniana , Estudios Prospectivos , Neoplasias de la Próstata/complicaciones , Recuperación de la Función , Medición de Riesgo , Factores de Tiempo , Resultado del Tratamiento
3.
Investig Clin Urol ; 58(3): 192-199, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28480345

RESUMEN

PURPOSE: Thulium vaporesection of the prostate (ThuVARP) is a new and safe approach for patients receiving anticoagulant therapy in whom transurethral resection of the prostate (TURP) may possess a high bleeding risk. We aimed to demonstrate the efficacy and safety of ThuVARP in patients receiving oral antiplatelet/anticoagulant (OAP/OAC) therapy. MATERIALS AND METHODS: A total of 103 patients who underwent ThuVARP between 2011 and 2013 were enrolled in the study. Patients were divided into 2 groups. Group A consisted of 47 patients who underwent low molecular weight heparin (LMWH) bridging and group B consisted of 56 patients who were operated on while receiving OAP/OAC therapy. RESULTS: The drop in hemoglobin levels in the pre- and postoperative periods was significantly higher in group A than in group B. When subgroups were analyzed, the mean drop in hemoglobin was significantly lower in the warfarin and ticlopidine subgroups of group B than in group A. International Prostate Symptom Scores were significantly lower 3, 12, 18, and 24 months after surgery in group A than in group B. Quality of life scores, maximal flow rate values, and postmicturition residual urine volumes (mL) were similar between the 2 groups. A total of 38 and 41 patients in groups A and B, respectively, had no complications. CONCLUSIONS: Our study showed the safety profile of continuing different OAP/OAC therapies in terms of bleeding problems in patients undergoing ThuVARP. We strongly recommend abandoning LMWH bridging and maintaining the OAP/OAC regimen patients are already receiving.


Asunto(s)
Anticoagulantes/uso terapéutico , Pérdida de Sangre Quirúrgica , Inhibidores de Agregación Plaquetaria/uso terapéutico , Resección Transuretral de la Próstata/métodos , Anciano , Anticoagulantes/administración & dosificación , Anticoagulantes/efectos adversos , Pérdida de Sangre Quirúrgica/prevención & control , Pérdida de Sangre Quirúrgica/estadística & datos numéricos , Heparina de Bajo-Peso-Molecular/uso terapéutico , Humanos , Terapia por Láser/efectos adversos , Terapia por Láser/métodos , Masculino , Atención Perioperativa/métodos , Inhibidores de Agregación Plaquetaria/administración & dosificación , Inhibidores de Agregación Plaquetaria/efectos adversos , Estudios Retrospectivos , Resección Transuretral de la Próstata/efectos adversos , Resultado del Tratamiento
4.
Arch Ital Urol Androl ; 89(4): 287-292, 2017 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-29473378

RESUMEN

OBJECTIVE: Clinical presentation of ureteral stones during pregnancy is generally with renal colic pain. The aim of this study is to present our experience in the management of renal colic during pregnancy in emergency settings. MATERIALS AND METHODS: 208 pregnant patients who presented to emergency department with renal colic pain and underwent ureteroscopy (URS) due to failed conservative therapy were enrolled in the study. Urinary tract stones were diagnosed either with ultrasound (US) examination or during URS. Laser lithotripsy and double J (DJ) stent placement were routinely done in all patients with ureteral stones. The incidence of infective complications and premature uterine contractions (PUC) due to URS were compared. RESULTS: No stone was identified in 36.1% (n = 75) of patients with using US and diagnostic URS. Of the remaining 133 patients, 30 (22.6%) had no stone at US but stones were diagnosed during diagnostic URS. The type of anesthesia had no significant effect on PUC. An increased risk of sepsis and PUC was found in patients with fever at the initial presentation. Interestingly, PUC was more frequent in patients with lower serum magnesium levels. There was a significant correlation with time delay until the intervention and the risk of urosepsis and PUC, individually. CONCLUSIONS: Ureteroscopy is a safe option for evaluation of pregnant patients with unresolved renal colic. According to the current findings, timing of the operation is the most important factor affecting the septic risks and abortion threat. Surgical intervention with URS must be planned as soon as possible.


Asunto(s)
Trabajo de Parto Prematuro/epidemiología , Cólico Renal/terapia , Cálculos Ureterales/terapia , Ureteroscopía/métodos , Urgencias Médicas , Femenino , Humanos , Incidencia , Litotripsia por Láser/métodos , Embarazo , Complicaciones del Embarazo/patología , Complicaciones del Embarazo/terapia , Estudios Retrospectivos , Stents , Factores de Tiempo , Resultado del Tratamiento , Ureteroscopía/efectos adversos
5.
Urology ; 99: 131-135, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27693574

RESUMEN

OBJECTIVE: To evaluate our experience in patients undergoing hybrid transvaginal natural orifices transluminal endoscopic surgery (NOTES) nephrectomy and evaluate the sexual functions in the postoperative period. MATERIALS AND METHODS: Prospective data of 71 patients with renal tumors who underwent hybrid NOTES radical nephrectomy in three different centers were collected from March 2010 to October 2015. Patient and surgical characteristics were recorded. Sexual function was evaluated using the Female Sexual Function Index questionnaire the day prior to the operation and 3 months after. RESULTS: The mean age, tumor size, and operation duration were 66.16 ± 11.21, 8.51 ± 3.31 cm, and 119.94 ± 21.38 minutes, respectively. Five patients were immediately reoperated due to bleeding from uterine veins. The complication risk increases significantly with increasing tumor size. Among the whole cohort, even the Female Sexual Function Index score differences are small; there is a statistically significant decrease in the postoperative period in all domains except sexual satisfaction. In fact, the patients reported unaltered sexual function after surgery and satisfaction with the result when asked directly. In subgroup analyses, in nulliparous patients (n = 60), arousal, sexual desire, orgasm, and satisfaction domains have no significant differences in pre- and postoperative periods. CONCLUSIONS: Hybrid NOTES nephrectomy is a feasible, safe operation that can be performed for large renal tumors. Due to incisions in the vaginal wall for specimen retrieval, sexual function can be altered in the postoperative period. So patient selection, preoperative evaluation, and close follow-up are mandatory. With this in mind, we strongly support the use of hybrid transvaginal NOTES nephrectomy for large renal tumors especially in nulliparous patients.


Asunto(s)
Carcinoma de Células Renales/cirugía , Neoplasias Renales/cirugía , Cirugía Endoscópica por Orificios Naturales/métodos , Nefrectomía/métodos , Conducta Sexual/fisiología , Sexualidad/fisiología , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Renales/diagnóstico , Estudios de Factibilidad , Femenino , Humanos , Neoplasias Renales/diagnóstico , Persona de Mediana Edad , Satisfacción del Paciente , Periodo Posoperatorio , Estudios Prospectivos , Encuestas y Cuestionarios , Resultado del Tratamiento , Vagina
7.
Case Rep Urol ; 2016: 2573476, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27579210

RESUMEN

Spontaneous subcapsular renal hematoma is a rare condition in clinical practice. It is caused by renal cysts, benign and malignant renal tumors, vascular lesions, and antiplatelet or anticoagulant therapy. In this paper we report an unusual case of rupture of a renal cyst of a 66-year-old male patient during an aortic and iliac endovascular procedure for a massive calcified atheroma above the iliac bifurcation. We suspected that the bolus of high weight molecular heparin given during the procedure caused the rupture of the cyst. According to the literature, this is the first case of renal cyst rupture during an endovascular aortic procedure after administering a high weight molecular heparin bolus.

10.
Arch Ital Urol Androl ; 88(4): 266-269, 2016 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-28073190

RESUMEN

OBJECTIVE: Endometriosis is an estrogendependent disease. The incidence of urinary tract endometriosis (UE) increased during the last few years and, nowadays, it ranges from 0.3 to 12% of all women affected by the disease. The ureter is the second most common site affected. The ureteral endometriosis is classified in extrinsic and intrinsic. The aim of this study is to individuate the best treatments for each subset of ureteral endometriosis. MATERIALS AND METHODS: 32 patients diagnosed with surgically treated UE were retrospectively reviewed. The patients were divided into 3 subsets (intrinsic UE, extrinsic UE with and without obstruction). The patients with intrinsic UE (n = 10) were treated with laser endoureterotomy. The patients with extrinsic UE (n = 22) were divided in two subsets with (n = 16) and without (n = 6) hydronephrosis. All the patients underwent ureteral stenting, and resection and reimplantation was performed in the first group, and when the mass was > 2.5 cm (n = 3) Boari flap was performed. Laparoscopic ureterolysis (shaving) was performed in the second group. RESULTS: In the extrinsic subset of UE, we obtained an high therapeutic success (84%). Conversely, in the intrinsic subset there was a recurrence rate of the disease in 6/10 of the patients (60%). CONCLUSIONS: Ureterolysis seems to be a good treatment in extrinsic UE without obstruction. Resection and reimplantation allows excellent results in the extrinsic UE with obstruction. In the intrinsic subset, the endoureterotomy approach is inadequate.


Asunto(s)
Endometriosis/cirugía , Enfermedades Ureterales/cirugía , Adulto , Endometriosis/clasificación , Femenino , Humanos , Persona de Mediana Edad , Estudios Retrospectivos , Enfermedades Ureterales/clasificación , Procedimientos Quirúrgicos Urológicos
11.
Arch Ital Urol Androl ; 88(4): 308-310, 2016 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-28073199

RESUMEN

Transrectal Ultrasound (TRUS) guided prostate biopsy is regarded as the gold standard for prostate cancer diagnosis. The majority of patients perceive TRUS-guided prostate biopsy as a physically and psychologically traumatic experience. We aimed to compare in this paper the efficacy of three different anesthesia techniques to control the pain during the procedure. MATERIALS AND METHODS: 150 patients who underwent transrectal ultrasound (TRUS) guided prostate biopsy were randomly divided into three groups. Group A included 50 patients who received one hour before the procedure a mixture of 2.5% lidocaine and 2.5% prilocaine, Group B: 50 patients who received intrarectal local anesthetic administration (lidocaine 5 ml 10%) and lidocaine local spray 15 % and Group C included 50 patients who received periprostatic block anesthesia (lidocaine 10 ml 10%). Visual analogue scale (VAS) of patients in different groups was evaluated at the end of the biopsy and 30 minutes after the procedure. RESULTS: The VAS of patients in Group A was 1.32 ± 0.65 (VAS I) and 2.47 ± 0.80 (VAS II). In group B the VAS of patients was 1.09 ± 0.47 (VAS I) and 1.65 ± 0.61 (VAS II). In group C the VAS of patients was 2.63 ± 0.78 (VAS I) and 1.70 ± 0.85 (VAS II). There was no statistically significant difference in term of VAS I between group A and B. A statistically significant difference was determined in terms of VAS II between group A and B. There was no statistically significant difference in term of VAS between group B and C. CONCLUSIONS: The most effective of the three methods for pain control we used was intrarectal local anesthetic administration and lidocaine local spray 15% that enables an ideal patient comfort.


Asunto(s)
Anestesia Local/clasificación , Manejo del Dolor/métodos , Próstata/patología , Neoplasias de la Próstata/patología , Ultrasonografía Intervencional , Anciano , Humanos , Biopsia Guiada por Imagen/efectos adversos , Masculino , Persona de Mediana Edad
12.
Ther Adv Urol ; 7(5): 235-40, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26425138

RESUMEN

OBJECTIVES: Locally advanced prostate cancer may cause several complications such as haematuria, bladder outlet obstruction, and renal failure due to the ureteral obstruction. Various treatments have been suggested, including radiotherapy, antifibrinolytics, bladder irrigation with alum solution, transurethral surgery and angioembolization, none of which have proven effectiveness. In the last years cryoablation has become a valid therapeutic option for prostate cancer. In our experience we used this 'new' technique as haemostatic therapy. METHODS: We selected four patients with gross haematuria affected by locally advanced hormone refractory prostate cancer, who had already been treated with primary radiotherapy. We used third-generation cryotherapy: under ultrasonographic guidance, we inserted six cryoprobes, two in each of the vascular pedicles reaching at least -60°C, and three thermometers. We then induced two freeze-thaw cycles. RESULTS: After the operation the haematuria stopped in all patients and at 9-month follow up we observed a mean of four red cells (range three to five) in the urinary sediment with no evidence of bacteriuria. Prostate volume, prostate-specific antigen and postmicturition residue were significantly reduced. Qmax improved significantly too. CONCLUSION: Our experience has given us good results with minimal intra- and postoperative complications. We think that haemostatic cryotherapy as a palliative approach for locally advanced prostate cancer could represent a valid treatment option and more consideration could be given to its use.

13.
Cir. Esp. (Ed. impr.) ; 93(6): 368-374, jun.-jul. 2015. ilus, tab
Artículo en Español | IBECS | ID: ibc-140080

RESUMEN

OBJETIVO: Evaluar la calidad de vida (QoL) y supervivencia global tras cistectomía radical con ureterostomías cutáneas por cáncer localmente avanzado de vejiga en pacientes ancianos con alto riesgo quirúrgico. MÉTODOS: Cincuenta y ocho pacientes, mayores de 74 años (edad media 80,6 ± 4,3) con cáncer de vejiga localmente avanzado (grupo A), fueron sometidos a una cistectomía radical y derivación ureterocutánea. Los pacientes completaron el cuestionario EORTC QLQC30 antes y 6 meses después de la cirugía para valoración de resultados funcionales, clínicos y de QoL. La misma evaluación fue realizada en un grupo control (grupo B) de 29 pacientes (edad media 82,3 ± 3,8 años), que habían rechazado la cistectomía. Los cuestionarios también fueron remitidos a pacientes de ambos grupos que sobrevivieron a los 20 meses y a los 5 años. RESULTADOS: Todos los pacientes presentaron un ASA ≥ 3. La estancia hospitalaria media fue de 15,1 días (± 4,8) en el grupo A y de 23,5 días (± 4,1) en el grupo B. No hubo complicaciones intraoperatorias en el grupo A. La supervivencia global postoperatoria evaluada a los 6 meses en el grupo A fue del 97 vs 79% en el grupo B (p < 0,001). La relación de calidad de vida e ítems de función y síntomas entre los 2 grupos a los 6 meses mostró una mejoría significativa de todos los parámetros en el grupo A (p < 0,001). Esta ventaja de los pacientes del grupo A fue todavía más evidente a los 20 meses y a los 5 años. La supervivencia a corto plazo y a los 20 meses fue significativamente mayor en el grupo A (p < 0,001). CONCLUSIÓN: La cistectomía radical con ureterostomía cutánea representa una alternativa válida en pacientes ancianos con cáncer de vejiga invasivo y alto riesgo quirúrgico. La comparación entre los grupos mostró una diferencia significativa en casi todos los parámetros relacionados con la QoL y con respecto a la supervivencia a corto y medio plazo


OBJECTIVE: To evaluate quality of life (QoL) and overall survival after radical cystectomy with cutaneous ureterostomies for locally advanced bladder cancer in elderly patients with high surgical risk. METHODS: Fifty eight patients older than 74 years (mean age 80,6 ± 4,3) with locally advanced bladder cancer (group A), underwent radical cystectomy and ureterocutaneous diversion. Patients completed the EORTC QLQC30 before and six months after surgery to assess functional, clinical and QoL outcomes. The same evaluation was carried out in a control group (group B) of 29 patients (mean age 82,3 ± 3,8 years), who had refused cystectomy. Questionnaires were also administered to patients of both groups who survived at least 20 months and 5 years. RESULTS: All patients presented with an ASA score ≥ 3. Mean hospital stay was 15.1 days (± 4.8) in group A and 23.5 days (± 4.1) in Group B. No intraoperative complications occurred in group A. Postoperative overall survival evaluated within 6 months in group A was 97% versus 79% in group B (p < 0.001). CONCLUSION: Radical cystectomy with cutaneous ureterostomy represents a valid alternative in elderly patients with invasive bladder cancer and high operative risk. Comparison between two groups showed a statistically significant difference for almost all the Qol related parameters and for short and medium term overall survival


Asunto(s)
Anciano de 80 o más Años , Anciano , Femenino , Humanos , Masculino , Cistectomía/estadística & datos numéricos , Neoplasias de la Vejiga Urinaria/cirugía , Indicadores de Calidad de Vida , Supervivencia sin Enfermedad , Complicaciones Posoperatorias/epidemiología , Derivación Urinaria/métodos , Factores de Riesgo
14.
Cir Esp ; 93(6): 368-74, 2015.
Artículo en Español | MEDLINE | ID: mdl-24054824

RESUMEN

OBJECTIVE: To evaluate quality of life (QoL) and overall survival after radical cystectomy with cutaneous ureterostomies for locally advanced bladder cancer in elderly patients with high surgical risk. METHODS: Fifty eight patients older than 74 years (mean age 80,6±4,3) with locally advanced bladder cancer (group A), underwent radical cystectomy and ureterocutaneous diversion. Patients completed the EORTC QLQC30 before and six months after surgery to assess functional, clinical and QoL outcomes. The same evaluation was carried out in a control group (group B) of 29 patients (mean age 82,3±3,8 years), who had refused cystectomy. Questionnaires were also administered to patients of both groups who survived at least 20 months and 5 years. RESULTS: All patients presented with an ASA score ≥3. Mean hospital stay was 15.1 days (±4.8) in group A and 23.5 days (±4.1) in Group B. No intraoperative complications occurred in group A. Postoperative overall survival evaluated within 6 months in group A was 97% versus 79% in group B (p<0.001). CONCLUSION: Radical cystectomy with cutaneous ureterostomy represents a valid alternative in elderly patients with invasive bladder cancer and high operative risk. Comparison between two groups showed a statistically significant difference for almost all the Qol related parameters and for short and medium term overall survival.


Asunto(s)
Cistectomía , Calidad de Vida , Ureterostomía , Neoplasias de la Vejiga Urinaria/mortalidad , Neoplasias de la Vejiga Urinaria/cirugía , Derivación Urinaria , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Estudios Retrospectivos , Medición de Riesgo , Tasa de Supervivencia , Derivación Urinaria/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA